GIORDANO, MIRELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.821
AS - Asia 1.500
EU - Europa 977
SA - Sud America 234
AF - Africa 116
Continente sconosciuto - Info sul continente non disponibili 111
OC - Oceania 1
Totale 5.760
Nazione #
US - Stati Uniti d'America 2.748
SG - Singapore 522
CN - Cina 371
IT - Italia 285
HK - Hong Kong 239
SE - Svezia 191
BR - Brasile 190
DE - Germania 182
VN - Vietnam 135
FR - Francia 57
GB - Regno Unito 56
CI - Costa d'Avorio 55
CA - Canada 51
IN - India 49
RU - Federazione Russa 38
BG - Bulgaria 37
FI - Finlandia 32
JP - Giappone 32
TR - Turchia 27
AT - Austria 19
BD - Bangladesh 19
NG - Nigeria 19
SN - Senegal 19
PL - Polonia 18
AR - Argentina 17
IQ - Iraq 15
ID - Indonesia 12
NL - Olanda 12
UA - Ucraina 12
PK - Pakistan 10
SA - Arabia Saudita 9
ZA - Sudafrica 9
KR - Corea 8
PH - Filippine 8
ES - Italia 7
IE - Irlanda 7
AZ - Azerbaigian 6
LT - Lituania 6
MA - Marocco 6
MX - Messico 6
VE - Venezuela 6
CO - Colombia 5
JO - Giordania 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
PE - Perù 4
EC - Ecuador 3
GT - Guatemala 3
IL - Israele 3
LU - Lussemburgo 3
OM - Oman 3
TH - Thailandia 3
BE - Belgio 2
CH - Svizzera 2
DZ - Algeria 2
EU - Europa 2
GE - Georgia 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
PY - Paraguay 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TW - Taiwan 1
Totale 5.651
Città #
Ashburn 430
Singapore 289
Dallas 265
Hong Kong 225
San Jose 198
Santa Clara 190
Chandler 172
Fairfield 139
Woodbridge 135
Houston 86
Beijing 83
Shanghai 83
New York 69
Pisa 67
Los Angeles 65
Seattle 61
Abidjan 55
Cambridge 53
Wilmington 48
Boardman 47
Council Bluffs 47
Florence 39
Sofia 37
Princeton 34
Bremen 33
Hanoi 32
Ho Chi Minh City 32
Munich 32
Frankfurt am Main 30
Lauterbourg 30
Lawrence 30
Tokyo 28
Milan 27
Ann Arbor 26
London 23
São Paulo 23
Serra 21
Buffalo 20
Dakar 19
Lagos 19
Warsaw 18
Turku 17
Istanbul 16
Medford 16
Ottawa 16
San Diego 16
Boulder 15
Vienna 15
Montreal 14
Des Moines 12
Ogden 12
Phoenix 12
Redondo Beach 11
Washington 11
Genoa 10
Hefei 10
Nanjing 9
Turin 9
Baghdad 8
Cascina 8
Denver 8
Dong Ket 8
Fuzhou 8
Haiphong 8
Toronto 8
Porto Alegre 7
Rome 7
Seoul 7
Baku 6
Boston 6
Dublin 6
Düsseldorf 6
Atlanta 5
Bologna 5
Chennai 5
Chicago 5
Da Nang 5
Dhaka 5
Guangzhou 5
Helsinki 5
Johannesburg 5
Kent 5
Nuremberg 5
Orem 5
Quanzhou 5
Rio de Janeiro 5
Tashkent 5
Amman 4
Brooklyn 4
Jakarta 4
Nanchang 4
Paris 4
Qingdao 4
Redmond 4
Riyadh 4
San José 4
Abu Dhabi 3
Ankara 3
Bangkok 3
Bergamo 3
Totale 3.805
Nome #
Aberrant expression of anaplastic lymphoma kinase in lung adenocarcinoma: Analysis of circulating free tumor RNA using one-step reverse transcription-polymerase chain reaction 248
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 223
C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer? 222
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 220
Differential microRNA expression profiles between young and old lung adenocarcinoma patients. 202
Expression Profiling of LKB1 Pathway in Young and Old Lung Adenocarcinoma Patients. 201
Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial 201
Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma 188
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients 176
Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study 174
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 170
Papillary Thyroid Carcinoma With Rare exon 15 BRAF Mutation Has Indolent Behavior: A Single-Institution Experience 156
Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma. 153
Differential microRNA Expression Profile between Young and Old Lung Adenocarcinoma Patients. 151
Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis 150
A Misleading Case of NTRK-Rearranged Papillary Thyroid Carcinoma 144
Feasibility of BRCA1/2 testing of formalin-fixed and paraffin-embedded pancreatic tumor samples: A consecutive clinical series 142
Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness 138
Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study 135
Expression of miRNA-25 in young and old lung adenocarcinoma 133
Prognostic role of TPL2 in early‑stage non‑small cell lung cancer 131
Tumor Regression Grading Assessment in Locally Advanced Pancreatic Cancer After Neoadjuvant FOLFIRINOX: Interobserver Agreement and Prognostic Implications 124
Molecular Pathology of Acinar Cystic Transformation 118
null 116
Molecular Pathology of Mucinous Cystic Neoplasms 116
Molecular Pathology of Serous Cystic Neoplasms 113
Molecular Subtypes of Pancreatic Ductal Adenocarcinoma 112
Molecular Pathology of Acinar Cell Carcinoma 109
Molecular screening with liquid biopsy for anti-EGFR retreatment in metastatic colorectal cancer: preliminary data from the randomized phase 2 PARERE trial 106
An Immune-Related Gene Expression Signature Predicts Benefit from Adding Atezolizumab to FOLFOXIRI plus Bevacizumab in Metastatic Colorectal Cancer 105
Molecular Pathology of Pancreatic Intraepithelial Neoplasms 103
Molecular Pathology of Neuroendocrine Tumors 103
Predictive Impact of RNF43 Mutations in Patients With Proficient Mismatch Repair/Microsatellite Stable BRAFV600E-Mutated Metastatic Colorectal Cancer Treated With Target Therapy or Chemotherapy 102
Molecular Pathology of Neuroendocrine Carcinoma 101
Molecular Pathology of Intraductal Papillary Mucinous Neoplasms 101
Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience 100
null 98
Molecular Pathology of Solid Pseudopapillary Neoplasms 97
Molecular Pathology of Pancreatic Ductal Adenocarcinoma 97
P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value 88
null 78
null 15
Totale 5.760
Categoria #
all - tutte 18.995
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.995


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022281 0 0 0 4 28 69 17 16 15 29 22 81
2022/2023641 71 94 41 69 58 68 6 45 139 5 40 5
2023/2024377 12 28 41 35 55 79 27 13 11 12 28 36
2024/20251.427 43 53 13 81 126 150 134 56 155 160 143 313
2025/20261.815 144 199 257 137 234 133 285 87 92 156 40 51
2026/2027299 41 145 113 0 0 0 0 0 0 0 0 0
Totale 5.760